Abbott Laboratories
SWB:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
SWB:ABL
|
US |
|
E
|
Endeavour Silver Corp
XMUN:EJD
|
CA |
|
P
|
Philip Morris International Inc
F:4I1
|
US |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
T
|
Toyota Motor Corp
XMUN:TOM
|
JP |
|
R
|
Royal Bank of Canada
NYSE:RY
|
CA |
|
C
|
Continental AG
MIL:CON
|
DE |
|
S
|
Sony Group Corp
SWB:SONA
|
JP |
|
G
|
Getinge AB
XMUN:GTN
|
SE |
|
Sanoma Oyj
F:SNQB
|
FI |
|
DSV A/S
CSE:DSV
|
DK |
|
Vulcan Materials Co
NYSE:VMC
|
US |
|
L'Oreal SA
PAR:OR
|
FR |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
P
|
Pacific Basin Shipping Ltd
F:OYD
|
HK |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 102.18 EUR with a low forecast of 77.8 EUR and a high forecast of 125.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
102.18
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 102.18 EUR with a low forecast of 77.8 EUR and a high forecast of 125.71 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
